Last Updated : July 7, 2010
Details
FilesGeneric Name:
Canakinumab
Project Status:
Complete
Therapeutic Area:
Cryopyrin-Associated Periodic Syndrome
Manufacturer:
Novartis Pharmaceuticals Canada Inc.
Call for patient/clinician input open:
Brand Name:
Ilaris
Project Line:
Reimbursement Review
Project Number:
SR0204-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Cryopyrin-Associated Periodic Syndrome (CAPS)
Recommendation Type:
Do not list
Final Recommendation:
Files
Last Updated : July 7, 2010